Clinical trial shows experimental drug safely slows progression of diabetic kidney disease

The findings, simultaneously published in the New England Journal of Medicine and presented at the American Society of Nephrology’s Kidney Week 2020 conference, show the investigational drug finerenone had tangible renal and cardiovascular benefits for patients with chronic kidney disease and type 2 diabetes. The 5,700-person phase III trial was led by George Bakris, MD, […]